Daiwa Securities Group Inc. - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 213 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.61 and the average weighting 0.2%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$5
-28.6%
1690.0%0.00%
Q2 2023$70.0%1690.0%0.00%
Q1 2023$70.0%1690.0%0.00%
Q4 2022$7
-99.9%
1690.0%0.00%
Q3 2022$9,000
-10.0%
1690.0%0.00%
Q2 2022$10,0000.0%169
+30.0%
0.00%
Q1 2022$10,000
+25.0%
1300.0%0.00%
Q4 2021$8,000
-11.1%
130
-14.5%
0.00%
Q3 2021$9,000
+80.0%
152
+85.4%
0.00%
Q2 2021$5,000
-16.7%
820.0%0.00%
Q1 2021$6,000
+20.0%
820.0%0.00%
Q4 2020$5,000
-64.3%
82
-65.3%
0.00%
Q3 2020$14,000
+75.0%
2360.0%0.00%
Q2 2020$8,0000.0%2360.0%0.00%
Q1 2020$8,000
-27.3%
2360.0%0.00%
Q4 2019$11,000
+10.0%
236
-9.9%
0.00%
Q3 2019$10,000
-9.1%
2620.0%0.00%
Q2 2019$11,000
+10.0%
2620.0%0.00%
Q1 2019$10,0000.0%262
+17.0%
0.00%
Q4 2018$10,000
-9.1%
2240.0%0.00%
Q3 2018$11,000
+57.1%
2240.0%0.00%
Q2 2018$7,0000.0%2240.0%0.00%
Q1 2018$7,0002240.00%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Tamarack Advisers, LP 360,000$21,845,0006.19%
Gagnon Advisors, LLC 213,217$12,938,0004.92%
GAGNON SECURITIES LLC 499,333$30,300,0004.30%
Spyglass Capital Management LLC 2,117,673$128,500,0002.86%
NEUMEIER POMA INVESTMENT COUNSEL LLC 646,530$39,231,0002.30%
Paulson & Co. 1,273,161$77,255,0001.85%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 212,112$12,871,0001.44%
Tygh Capital Management, Inc. 152,332$9,244,0001.26%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,147,000$69,600,0001.24%
Rock Springs Capital Management LP 1,025,000$62,197,0001.23%
View complete list of PACIRA PHARMACEUTICALS INC shareholders